Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have shown that increasing survival rates in cardiogenic shock is challenging.

It can also improve the experience of participants by mapping patients’ anamnesis to the clinical design ... accelerate this process. Preparing consent forms for trials can also be optimised ...

This enables regulatory reviewers to evaluate and process clinical trials more effectively ... To find out more, download our free guide to STDM mapping. Standard for Exchange of Non-Clinical ...

Shifting from a regulatory role to driving innovation directly, Eydelman discusses how the Collaborative Community on ...

Not all trauma treatments are created equal. Structure, science, and the right plan can make all the difference in healing ...

Have you heard of brainspotting? It's been around since 2003 when it was invented out of whole cloth (not "discovered") by psychotherapist David Grand. It seems to be gaining in popularity recently, ...

Axtria InsightsMAx.ai solves the "last-mile problem" in AI implementation, and seamless experimentation-to-production ...

Lantern Pharma Inc. ( NASDAQ: LTRN) Q1 2025 Earnings Conference Call May 15, 2025 9:00 AM ET Panna Sharma - President & CEO David Margrave - CFO ...

Discover the multiple sclerosis (MS) patterns that standard brain scans frequently overlook and why these missed indicators ...

Baystreet.ca News Commentary – The U.S. Food and Drug Administration (FDA) gave another major boost to the use of Artificial Intelligence (AI) in healthcare through the full ...

Hopkins neuroscientist Richard Huganir is close to finding a potential life-changing treatment for kids with SYNGAP1-related ...